Literature DB >> 3683469

Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease.

J B Kruskal1, P J Commerford, J J Franks, R E Kirsch.   

Abstract

Coronary-artery thrombosis may be important in the pathogenesis of unstable angina at rest. To study this possibility, we measured the serum concentrations of fibrin-related antigen, D dimer (the principal breakdown fragment of fibrin), and fibrin monomer (an intermediate product of fibrin formation) in the serum of five groups of subjects. These included 10 healthy controls, 10 controls with noncardiac pain, and three groups of 10 patients each with chronic stable angina, unstable angina at rest, or acute myocardial infarction. The concentration of fibrin-related antigen (normal range, 48 to 184 ng per milliliter) was normal in the control patients with noncardiac pain (63 to 202 ng per milliliter) and in patients with chronic stable angina (95 to 186), but it was increased in patients with unstable angina (401 to 2507) or acute myocardial infarction (470 to 1930) (P less than 0.001). D dimer concentrations in patients with unstable angina (178.3 to 310.6 ng per milliliter) or acute myocardial infarction (103.9 to 321.6) were higher than those in patients with chronic stable angina (28.6 to 52.1), in controls with noncardiac pain (44.7 to 53.1), and in healthy controls (40.4 to 50.3) (P less than 0.001). Concentrations of fibrin monomer were highest in patients with acute myocardial infarction (247.5 to 571.3 ng per milliliter) (P less than 0.001), intermediate in those with unstable angina (54.7 to 241.7) (P less than 0.001), and normal (normal range, 14.5 to 19.8 ng per milliliter) in controls with noncardiac pain (12.0 to 18.4). and patients with chronic stable angina (10.7 to 17.6). These findings suggest the presence of an active thrombotic process in patients with unstable angina at rest or acute myocardial infarction. The data do not prove that the coronary arteries were the site of the thrombotic process, but the observations are consistent with the hypothesis that thrombus formation may have an important role in the pathogenesis of these conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683469     DOI: 10.1056/NEJM198711263172201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  17 in total

1.  Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism.

Authors:  J Lichey; I Reschofski; T Dissmann; M Priesnitz; M Hoffmann; H Lode
Journal:  Klin Wochenschr       Date:  1991-08-16

Review 2.  Therapeutic options in treating acute myocardial infarction.

Authors:  J W Danforth
Journal:  West J Med       Date:  1989-10

3.  Thrombotic reactant markers in non-ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractionated heparin.

Authors:  E Gurfinkel; E Duronto; C Colorio; G Bozovich; M Cohen; B Mautner
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

4.  Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.

Authors:  A Ceriello; C Taboga; L Tonutti; R Giacomello; L Stel; E Motz; M Pirisi
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

Review 5.  Bimodal presentation of the clinical syndromes of coronary atherosclerosis: a review.

Authors:  P J Commerford
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

Review 6.  Fibrinogen and coronary risk.

Authors:  W Koenig
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

Review 7.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.

Authors:  I F Godsland; U Winkler; O Lidegaard; D Crook
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 8.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.

Authors:  A Ceriello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

Review 9.  Unstable angina: current concepts of medical management.

Authors:  C W Hamm; W Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

10.  Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome.

Authors:  I Wieczorek; W G Haynes; D J Webb; C A Ludlam; K A Fox
Journal:  Br Heart J       Date:  1994-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.